TolerogenixX
Developer of a patented and clinically tested cell therapy technique created for individualized immunosuppression in transplant patients. The company's cell therapy technique helps in the targeted disabling of undesired reactions caused by the immune system's defenses, enabling patients who received transplants to become tolerant of the donated organ.
Heidelberg, GermanyOtherStartup
Partnerships
Team
Similar to TolerogenixX
